Mostrando 5 resultados de: 5
Filtros aplicados
Erythropoiesis-stimulating agents for myelodysplastic syndromes
ReviewAbstract: This is the protocol for a review and there is no abstract. The objectives are as follows: To assessPalabras claves:Autores:Acevedo A.M., Becerra H.A., Cardona A.F., Prada-Mancilla W., Prof. Arturo Martí Carvajal MD MSc Ph.D iD, Rodríguez M.L.Fuentes:scopusEculizumab for treating patients with paroxysmal nocturnal hemoglobinuria
ReviewAbstract: Background: Paroxysmal nocturnal hemoglobinuria (PNH) is a chronic, not malignant, disease of the hePalabras claves:Autores:Anand V., Cardona A.F., Prof. Arturo Martí Carvajal MD MSc Ph.D iD, Sola I.Fuentes:googlescopusInterventions for previously untreated patients with AIDS-associated non-Hodgkin's lymphoma
ReviewAbstract: Background: Human immunodeficiency virus (HIV) infection is known to be associated with an increasedPalabras claves:Autores:Cardona A.F., Lawrence A., Prof. Arturo Martí Carvajal MD MSc Ph.D iDFuentes:scopusInterventions for treating AIDS-associated Hodgkin' s lymphoma in treatment-naive adults
ReviewAbstract: Background: Hodgkin's disease (HD) is the most common non-AIDS-defining malignancy in HIV-infected pPalabras claves:adult, AIDS-related [*therapy], humans, LymphomaAutores:Cardona A.F., Prof. Arturo Martí Carvajal MD MSc Ph.D iD, Rodríguez M.L.Fuentes:scopusImatinib for treating newly diagnosed chronic myeloid leukemia patients
ArticleAbstract: This is the protocol for a review and there is no abstract. The objectives are as follows: To assessPalabras claves:Autores:Acevedo A.M., Anand V., Cardona A.F., Daniel Simancas-Racines, Gupta P., Prof. Arturo Martí Carvajal MD MSc Ph.D iD, Sola I.Fuentes:scopus